Wesley Medical Research

ImmusanT has announced it will be launching Phase 2 Nexvax2® trial in Australia, for the treatment of coeliac disease. Dr James Daveson, Gastroenterologist and member of Coeliac Australia Medical Advisory Committee, is one of the lead Australian investigators. 

In addition to his involvement with Nexvax2®, Dr James Daveson has been working with Wesley Medical Research to advance diagnostic and management techniques including the coeliac pin prick test. This test could lead to simpler, faster diagnosis – an important step in preventing further complications from the auto-immune disease which is triggered by gluten.